ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Oncology Unit – How To Plan, Start It

February 10, 1978

Two More CHOPs Funded By NCI

March 6, 1981

NCI Grant Awards

October 8, 1993

New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome

November 28, 2003

Possible Government Shutdown Looms Over Biomedical Research Funding Once More

September 23, 2011

DRCCA Board Again Approves Breast Cancer Dietary Study

May 13, 1983